MRD作为多发性骨髓瘤的预后指标和临床试验终点的作用

{"title":"MRD作为多发性骨髓瘤的预后指标和临床试验终点的作用","authors":"C. O. Landgren","doi":"10.25270/JCP.2019.04.00070","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":73670,"journal":{"name":"Journal of clinical pathways : the foundation of value-based care","volume":"33 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2019-04-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Role of MRD as Prognostic Indicator, Clinical Trial Endpoint for Multiple Myeloma\",\"authors\":\"C. O. Landgren\",\"doi\":\"10.25270/JCP.2019.04.00070\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":73670,\"journal\":{\"name\":\"Journal of clinical pathways : the foundation of value-based care\",\"volume\":\"33 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2019-04-16\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of clinical pathways : the foundation of value-based care\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.25270/JCP.2019.04.00070\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of clinical pathways : the foundation of value-based care","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.25270/JCP.2019.04.00070","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}